Soteri Skin

About:

Soteri Skin is a clinically-tested eczema relief topical company

Website: https://soteriskin.com

Top Investors: Y Combinator

Description:

Company Overview: Soteri Skin Inc. is a clinically tested, consumer skin health start-up that has participated in both the YC accelerator program (W22) and Harvard Innovation Labs. At Soteri Skin, we are revolutionizing treatments for Atopic Dermatitis (eczema) with our patented technology, trademarked as Soteri Skin’s signature pH/LOCK™ complex. This innovative approach offers an outside-in pathway to treating eczema by repairing the skin barrier. It accomplishes this by restoring the skin's acid mantle, and correcting the skin pH to an optimal level of 4.7 for a full 12 hours. This creates an ideal environment for skin renewal and supports a healthy skin microbiome, both essential for repairing the skin barrier. A stronger, more resilient skin barrier prevents allergens, pathogens, and harmful bacteria from penetrating the skin and causing inflammation while locking in moisture.

Total Funding Amount:

$500000

Headquarters Location:

San Francisco, California, United States

Founded Date:

2022-01-01

Contact Email:

hi(AT)soteriskin.com

Founders:

Lama Mansour, Rafal Pielak

Number of Employees:

1-10

Last Funding Date:

2022-03-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai